Related Experiment Video

Updated: May 18, 2026

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

Selected cytokine profiles during remission in bipolar patients

Agnieszka Remlinger-Molenda1, Pawel Wojciak, Michal Michalak

  • 1Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland. aremlinger@gmail.com

Neuropsychobiology
|September 6, 2012
PubMed

Insights

Bipolar patients in sustained remission show normalized cytokine levels, similar to healthy individuals. Immediate remission after mania or depression reveals distinct cytokine alterations, highlighting the impact of long-term treatment on immune status.

Area of Science:

  • Neuroimmunology
  • Psychiatry
  • Immunology

Background:

  • Bipolar disorder is associated with altered immune system function and cytokine dysregulation.
  • Cytokine profiles may differ based on the phase of illness and remission status in bipolar disorder.

Purpose of the Study:

  • To investigate the cytokine status in bipolar patients during immediate and sustained remission.
  • To compare cytokine levels in remitted bipolar patients with those of healthy controls.

Main Methods:

  • Serum concentrations of key cytokines (IL-1β, IL-2, IL-6, IL-10, TNF-α, IFN-γ) were measured.
  • Participants included 121 bipolar patients (immediate/sustained remission) and 78 healthy controls.
  • Cytokine levels were determined using the Human Th1/Th2 Cytometric Bead Array method.

Main Results:

  • Elevated Interleukin-10 (IL-10) was observed in patients remitting from mania.
  • Increased Interferon-gamma (IFN-γ) was found in patients remitting from depression.
  • Patients in sustained remission (≥6 months) exhibited cytokine concentrations comparable to healthy controls.

Conclusions:

  • Sustained remission in bipolar disorder, particularly with lithium maintenance, normalizes the cytokine profile.
  • Immediate remission phases are characterized by specific cytokine alterations, suggesting ongoing immune system changes.
  • Long-term mood stabilization may restore immune homeostasis in bipolar patients.
Abstract

More Related Videos

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...